Company Registration No. 02108509 (England and Wales)
A B Pharmaceuticals Limited
Unaudited accounts
for the year ended 31 March 2023
A B Pharmaceuticals Limited
Unaudited accounts
Contents
A B Pharmaceuticals Limited
Company Information
for the year ended 31 March 2023
Directors
Mr A J Barstow
Mrs A J Barstow
Mr A Barstow
Mr C Barstow
Company Number
02108509 (England and Wales)
Registered Office
1 Sticklepath Court
Tawstock
Barnstaple
Devon
EX31 3HN
Accountants
CJM Accounting Limited
Beacon Hill House
Bicknoller
Taunton
West Somerset
TA4 4ER
A B Pharmaceuticals Limited
Statement of financial position
as at 31 March 2023
Cash at bank and in hand
160,853
24,544
Creditors: amounts falling due within one year
(1,272)
(1,221)
Net current assets
159,581
23,742
Net assets
159,581
109,536
Called up share capital
500
500
Profit and loss account
159,081
109,036
Shareholders' funds
159,581
109,536
For the year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 12 May 2023 and were signed on its behalf by
Mr A J Barstow
Director
Company Registration No. 02108509
A B Pharmaceuticals Limited
Notes to the Accounts
for the year ended 31 March 2023
A B Pharmaceuticals Limited is a private company, limited by shares, registered in England and Wales, registration number 02108509. The registered office is 1 Sticklepath Court, Tawstock, Barnstaple, Devon, EX31 3HN.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in sterling.
Turnover represents the value, net of Value Added Tax, of goods and services supplied to customers during the year. Sales are recognised at the point at which the company has fulfilled its contractual obligations and the risks and rewards attaching to the product have been transferred to the customer.
Tangible fixed assets are stated at cost less depreciation. Cost represents purchase price together with any incidental costs of acquisition.
Depreciation is calculated so as to write off the cost of an asset, net of any estimated residual value, over their expected useful economic lives as follows:
Land & buildings
2% straight line
Fixtures & fittings
15% straight line
Computer equipment
25% straight line
Fixed asset investments are shown at historic cost less provision for any permanent diminution in value.
A B Pharmaceuticals Limited
Notes to the Accounts
for the year ended 31 March 2023
4
Tangible fixed assets
Land & buildings
Fixtures & fittings
Computer equipment
Total
Cost or valuation
At cost
At cost
At cost
At 1 April 2022
139,601
5,803
2,384
147,788
Disposals
(139,601)
(5,803)
(2,384)
(147,788)
At 1 April 2022
53,808
5,803
2,384
61,995
On disposals
(53,808)
(5,803)
(2,384)
(61,995)
At 31 March 2022
85,793
-
-
85,793
5
Investments
Other investments
Valuation at 1 April 2022
1
Valuation at 31 March 2023
-
Amounts falling due within one year
7
Creditors: amounts falling due within one year
2023
2022
Taxes and social security
22
21
Allotted, called up and fully paid:
125 Ordinary A shares of £1 each
125
125
125 Ordinary B shares of £1 each
125
125
125 Ordinary C shares of £1 each
125
125
125 Ordinary D shares of £1 each
125
125
A B Pharmaceuticals Limited
Notes to the Accounts
for the year ended 31 March 2023
9
Average number of employees
During the year the average number of employees was 2 (2022: 2).